Live Market Updates
Latest Financial News
News Feed
1 articles
Personalized
Live Market Updates
Latest Financial News
positive
5h agoBiotech startup Helex raises US$3.5 million seed round to advance gene-therapy research
Helex, a biotech startup headquartered in Hyderabad and the United States, has successfully raised US$3.5 million in a seed funding round led by pi Ventures, with participation from Bluehill Capital, SOSV and other global investors. The company will use the funds to expand its research and development in gene-therapy solutions for chronic kidney disease and other rare genetic disorders, bolster its laboratory infrastructure and hire additional scientific talent. Helex’s move underlines increasing investor interest in Indian-origin biotech firms with global ambitions.
Explore:Mutual Fund Tools
positive
5h agoBiotech startup Helex raises US$3.5 million seed round to advance gene-therapy research
Helex, a biotech startup headquartered in Hyderabad and the United States, has successfully raised US$3.5 million in a seed funding round led by pi Ventures, with participation from Bluehill Capital, SOSV and other global investors. The company will use the funds to expand its research and development in gene-therapy solutions for chronic kidney disease and other rare genetic disorders, bolster its laboratory infrastructure and hire additional scientific talent. Helex’s move underlines increasing investor interest in Indian-origin biotech firms with global ambitions.
Explore:Mutual Fund Tools
Breaking
positive
Biotech startup Helex raises US$3.5 million seed round to advance gene-therapy research
about 5 hours ago
1 min read
81 words
Indian-US biotech startup Helex secured US$3.5 m seed funding led by pi Ventures to advance gene-therapy R&D for kidney and rare-disease targets.
Helex, a biotech startup headquartered in Hyderabad and the United States, has successfully raised US$3.5 million in a seed funding round led by pi Ventures, with participation from Bluehill Capital, SOSV and other global investors. The company will use the funds to expand its research and development in gene-therapy solutions for chronic kidney disease and other rare genetic disorders, bolster its laboratory infrastructure and hire additional scientific talent. Helex’s move underlines increasing investor interest in Indian-origin biotech firms with global ambitions.
Helex, a biotech startup headquartered in Hyderabad and the United States, has successfully raised US$3.5 million in a seed funding round led by pi Ventures, with participation from Bluehill Capital, SOSV and other global investors. The company will use the funds to expand its research and development in gene-therapy solutions for chronic kidney disease and other rare genetic disorders, bolster its laboratory infrastructure and hire additional scientific talent. Helex’s move underlines increasing investor interest in Indian-origin biotech firms with global ambitions.
Companies:
Helex
Tags:
startups
biotech
startups
biotech
funding
healthcare
India
Oct 30, 2025 • 20:44 IST